methoxyhydroxyphenylglycol has been researched along with MS (Multiple Sclerosis) in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evangelopoulos, ME; Karahalios, G; Koutsis, G; Mandellos, D; Markianos, M; Sfagos, C | 1 |
| Andersen, O; Johansson, BB; Svennerholm, L | 1 |
| Davidson, D; Kinloch, N; Mawdsley, C; Pullar, IA; Yates, CM | 1 |
| Sharpless, NS; Thal, LJ; Wolfson, LI | 1 |
4 other study(ies) available for methoxyhydroxyphenylglycol and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
Topics: Adolescent; Adult; Disability Evaluation; Disease Progression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple Sclerosis; Neurotransmitter Agents; Regression Analysis; Severity of Illness Index; Young Adult | 2009 |
Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
Topics: Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Multiple Sclerosis; Phenylacetates | 1981 |
Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
Topics: Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Multiple Sclerosis; Phenylacetates; Recurrence | 1977 |
Diminished levels of ventricular fluid norepinephrine metabolite and somatostatin in childhood-onset dystonia.
Topics: Adolescent; Adult; Age Factors; Cerebral Palsy; Child; Child, Preschool; Dystonia; Homovanillic Acid; Humans; Hydrocephalus; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Multiple Sclerosis; Norepinephrine; Parkinson Disease; Somatostatin | 1988 |